Syncell Inc logo — Enabling Microscopy-Guided Subcellular Proteomic Discovery

Syncell Inc

Enabling Microscopy-Guided Subcellular Proteomic Discovery

Founded 2020 Taiwan Taiwan 58 employees Convertible Note Total: $15.10M Life Sciences

General Information

Company Name Syncell Inc
Founded Year 2020
Location Taiwan Taiwan +1
Employees 58
Industries Life Sciences
Funding Stage Convertible Note
Social

Get notified when Syncell Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Syncell Inc

SYNCELL INC. is a Taiwan-based life science tools company founded in 2020, with a focused mission on revolutionizing proteome and biomarker discovery. The company's innovative Microscoop platform is a subcellular "pickable" microscope that enables researchers to isolate and identify proteins at specific locations under the microscope, thus enabling hypothesis-free subcellular spatial proteomics with high sensitivity and specificity. This groundbreaking technology marks a significant shift in the field of proteomic discovery, allowing for the identification of novel molecular mechanisms and biomarkers for diseases. At the forefront of technological innovation, SYNCCELL INC. received a noteworthy $8.10M Convertible Note investment on 13th October 2023, indicative of the confidence and interest from potential investors in the company's pioneering approach. As the company continues to push the boundaries of life science tools, it is poised to make substantial contributions to the field of proteomic discovery and disease research.

Taxonomy: Life science tools, Proteome discovery, Biomarker identification, Spatial biology, Spatial proteomics, Subcellular proteomics, Microscopy, Cellular imaging, Molecular mechanisms, Disease biomarkers, Spatial omics, High sensitivity, High specificity, Cell and tissue analysis, Research technology

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• - 13 Oct 2023
Seed Round •••••• 1
Investor
15 Sep 2023
Seed Round •••••• - 29 Apr 2022
Seed Round •••••• - 28 Dec 2021

Syncell Inc Alternatives & Competitors

Syncell Inc vs
Nucleai
Nucleai United States

The leading Spatial Biology Software Platform for Precision Medicine.

Series Unknown
105 employees
AI, Health Care
Syncell Inc vs
Sirona Dx
Sirona Dx United States

The I-O Clinical Service Laboratory

11 employees
Biotechnology
Syncell Inc vs

Empowering Protein Discovery | Antibodies Validated by the Human Protein Atlas

Seed
69 employees
Biotechnology
Also compare with: Syncell Inc vs Vizgen Vizgen

FAQ About Syncell Inc

Enabling Microscopy-Guided Subcellular Proteomic Discovery
Syncell Inc was founded in 2020.
Syncell Inc is headquartered in Taiwan.
Syncell Inc operates in the following industries: Life Sciences.
Syncell Inc has approximately 58 employees.
Syncell Inc has completed 4 funding rounds, raising a total of $15.10M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Syncell Inc include Nucleai, Sirona Dx, Atlas Antibodies, Singular Genomics, Vizgen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Syncell Inc and Nucleai are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Syncell Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy